| Phase II trial of stereotactic ablative radiation for oligoprogressive metastatic kidney cancer R Hannan, M Christensen, H Hammers, A Christie, B Paulman, D Lin, ... European urology oncology 5 (2), 216-224, 2022 | 36 | 2022 |
| Oncologist perspectives on telemedicine for patients with cancer: a national comprehensive cancer network survey AJ Tevaarwerk, T Chandereng, T Osterman, W Arafat, J Smerage, ... JCO oncology practice 17 (9), e1318-e1326, 2021 | 36 | 2021 |
| Stereotactic ablative radiation therapy for oligoprogressive renal cell carcinoma JE Schoenhals, O Mohamad, A Christie, Y Zhang, D Li, N Singla, ... Advances in Radiation Oncology 6 (5), 100692, 2021 | 26 | 2021 |
| Stereotactic Ablative Radiation for Systemic Therapy–naïve Oligometastatic Kidney Cancer R Hannan, M Christensen, A Christie, A Garant, I Pedrosa, L Robles, ... European urology oncology 5 (6), 695-703, 2022 | 24 | 2022 |
| Development and initial clinical testing of a multiplexed circulating tumor cell assay in patients with clear cell renal cell carcinoma RM Bade, JL Schehr, H Emamekhoo, BK Gibbs, TS Rodems, ... Molecular oncology 15 (9), 2330-2344, 2021 | 18 | 2021 |
| Overcoming sociodemographic factors in the care of patients with testicular cancer at a safety net hospital N Chertack, RA Ghandour, N Singla, Y Freifeld, RC Hutchinson, ... Cancer 126 (19), 4362-4370, 2020 | 15 | 2020 |
| Phase II trial of stereotactic ablative radiation (SAbR) for oligometastatic kidney cancer. R Hannan, M Christensen, L Robles, A Christie, A Garant, NB Desai, ... Journal of Clinical Oncology 39 (6_suppl), 311-311, 2021 | 10 | 2021 |
| Very late relapse of germ cell tumor as a teratoma: a case report and review of the literature W Arafat, C Albany, TM Ulbright, R Foster, LH Einhorn Journal of Surgical Case Reports 2014 (6), rju051, 2014 | 6 | 2014 |
| Feasibility of institution‐agnostic, EHR‐integrated regional clinical trial matching SP Shriver, W Arafat, C Potteiger, DL Butler, MS Beg, M Hullings, S Semy, ... Cancer 130 (1), 60-67, 2024 | 4 | 2024 |
| Getting ready for real‐world use of electronic patient‐reported outcomes (ePROs) for patients with cancer: A National Comprehensive Cancer Network ePRO Workgroup paper JR Cracchiolo, W Arafat, A Atreja, L Bruckner, H Emamekhoo, T Heinrichs, ... Cancer 129 (16), 2441-2449, 2023 | 4 | 2023 |
| BIO21-011: Oncology Provider Perspectives on Telemedicine for Patients With Cancer: A National Comprehensive Cancer Network (NCCN®) Survey A Tevaarwerk, T Osterman, W Arafat, J Smerage, FCG Polubriaginof, ... Journal of the National Comprehensive Cancer Network 19 (3.5), BIO21-011 …, 2021 | 4 | 2021 |
| Intra-patient heterogeneity in urothelial cancer (UC) circulating tumor cells (CTC) and PDL1 expression to identify biomarkers of response and new therapeutic targets: A pilot … W Arafat, C Stahlfeld, JM Sperger, E Heninger, D Gopalakrishnan, ... Journal of Clinical Oncology 35 (15_suppl), 4537-4537, 2017 | 4 | 2017 |
| Disparities in Pre-Orchiectomy Sperm Cryopreservation Among Testicular Cancer Patients at a Public Safety Net Hospital and a Private Tertiary Care Center A Patel, JM Howard, N Chertack, RR Badia, V Margulis, SL Woldu, ... Urology 163, 126-131, 2022 | 3 | 2022 |
| Prophylaxis against thromboembolic events during chemotherapy for germ cell cancer X Meng, M Ahmed, KD Courtney, W Arafat, I Ibrahim, V Margulis, ... Frontiers in Oncology 11, 724682, 2021 | 3 | 2021 |
| Phase II trial of stereotactic ablative radiation (SAbR) for oligoprogressive kidney cancer. R Hannan, M Christensen, A Garant, HJ Hammers, W Arafat, KD Courtney, ... Journal of Clinical Oncology 39 (15_suppl), 4564-4564, 2021 | 2 | 2021 |
| Development and clinical validation of circulating tumor cell (CTC) biomarkers in clear cell renal cell carcinoma (ccRCC) for the OMNIVORE clinical trial. W Arafat, J Desotelle, T Rodems, RR McKay, J Abel, TK Choueiri, ... Journal of Clinical Oncology 35 (15_suppl), 4579-4579, 2017 | 2 | 2017 |
| Inferior vena cava filter-appropriate use and retrieval R Shah, A Turk, B Rahim, W Arafat, M Nazeef, RJ Mattison Blood 128 (22), 5912, 2016 | 2 | 2016 |
| Clinician Perspectives Regarding the Impact of Information Technology on Multidisciplinary Tumor Boards: A National Comprehensive Cancer Network Survey W Arafat, P Fu Jr, AJ Wagner, T Osterman, DB Martin, J Sugalski, ... JCO Clinical Cancer Informatics 7, e2300056, 2023 | | 2023 |
| Extracranial palliative radiotherapy for metastatic renal cell carcinoma. YS Kwon, E Hsu, M Stein, A Christie, A Garant, AZ Wang, DX Yang, A Yen, ... Journal of Clinical Oncology 41 (16_suppl), e24156-e24156, 2023 | | 2023 |
| Oncologist perspectives on tumor boards: Virtual meetings and EHR integration. W Arafat, P Fu, AJ Wagner, T Osterman, D Martin, J Sugalski, T Heinrichs, ... Journal of Clinical Oncology 40 (28_suppl), 46-46, 2022 | | 2022 |
Hans HammersUT SouthwesternVerified email at utsouthwestern.edu
